Nektar Therapeutics Stock Price on January 4, 2025
| NKTR Stock | USD 1.10 0.14 14.58% |
Below is the normalized historical share price chart for Nektar Therapeutics extending back to May 03, 1994. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Nektar Therapeutics stands at 1.10, as last reported on the 6th of January, with the highest price reaching 1.16 and the lowest price hitting 0.96 during the day.
If you're considering investing in Nektar Stock, it is important to understand the factors that can impact its price. Nektar Therapeutics has Sharpe Ratio of -0.0429, which conveys that the firm had a -0.0429% return per unit of risk over the last 3 months. Nektar Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Nektar Therapeutics' Risk Adjusted Performance of (0.02), mean deviation of 3.07, and Standard Deviation of 4.14 to check out the risk estimate we provide.
At this time, Nektar Therapeutics' Common Stock Shares Outstanding is relatively stable compared to the past year. As of 01/06/2025, Liabilities And Stockholders Equity is likely to grow to about 707.3 M, while Common Stock Total Equity is likely to drop slightly above 16.2 K. . As of 01/06/2025, Price To Sales Ratio is likely to drop to 1.30. In addition to that, Price Earnings Ratio is likely to drop to -0.37. Nektar Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 3rd of May 1994 | 200 Day MA 1.2674 | 50 Day MA 1.117 | Beta 0.61 |
Nektar |
Sharpe Ratio = -0.0429
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NKTR |
Estimated Market Risk
| 4.23 actual daily | 37 63% of assets are more volatile |
Expected Return
| -0.18 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Nektar Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nektar Therapeutics by adding Nektar Therapeutics to a well-diversified portfolio.
Price Book 4.1507 | Enterprise Value Ebitda (6.50) | Price Sales 2.1786 | Shares Float 155 M | Wall Street Target Price 4.7 |
Related Headline
Assembly Biosciences Headline on 3rd of January 2025
Atypical journalists probe Gurmit Singhs speeding scandal, i... by channelnewsasia.com
What happens when a group of neurodivergent individuals get to quiz big names like Gurmit Singh and President Tharman The Assembly brings open conversations to the forefront, in a format that is the first of its kind in Asia.
Nektar Therapeutics Valuation on January 4, 2025
It is possible to determine the worth of Nektar Therapeutics on a given historical date. On January 4, 2025 Nektar was worth 0.96 at the beginning of the trading date compared to the closed value of 1.1. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Nektar Therapeutics stock. Still, in general, we apply an absolute valuation method to find Nektar Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Nektar Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Nektar Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 0.96 | 1.02 | 0.93 | 0.96 | 909,106 | |
01/03/2025 | 0.96 | 1.16 | 0.96 | 1.10 | 2,795,303 |
| 0.96 | 1.16 | 0.96 | 1.10 | 0.00 |
| Backtest Nektar Therapeutics | | | Nektar Therapeutics History | | | Nektar Therapeutics Valuation | Previous | Next |
Nektar Therapeutics Trading Date Momentum on January 4, 2025
| On January 06 2025 Nektar Therapeutics was traded for 1.10 at the closing time. The top price for the day was 1.16 and the lowest listed price was 0.96 . There was no trading activity during the period 0.0. Lack of trading volume on January 6, 2025 did not cause price change. The trading delta at closing time against the current closing price is 12.73% . |
Nektar Therapeutics Fundamentals Correlations and Trends
By evaluating Nektar Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Nektar Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Nektar financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Nektar Therapeutics Stock history
Nektar Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Nektar is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Nektar Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Nektar Therapeutics stock prices may prove useful in developing a viable investing in Nektar Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 218.5 M | 229.4 M | |
| Net Loss | -331.4 M | -314.8 M |
Nektar Therapeutics Quarterly Net Working Capital |
|
Nektar Therapeutics Stock Technical Analysis
Nektar Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Nektar Therapeutics Period Price Range
Low | January 6, 2025
| High |
0.00 | 0.00 |
Nektar Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Nektar Therapeutics January 6, 2025 Market Strength
Market strength indicators help investors to evaluate how Nektar Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nektar Therapeutics shares will generate the highest return on investment. By undertsting and applying Nektar Therapeutics stock market strength indicators, traders can identify Nektar Therapeutics entry and exit signals to maximize returns
Nektar Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Nektar Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Nektar Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Nektar to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.19) | |||
| Total Risk Alpha | (0.24) | |||
| Treynor Ratio | (0.17) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Nektar Stock Analysis
When running Nektar Therapeutics' price analysis, check to measure Nektar Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nektar Therapeutics is operating at the current time. Most of Nektar Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nektar Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nektar Therapeutics' price. Additionally, you may evaluate how the addition of Nektar Therapeutics to your portfolios can decrease your overall portfolio volatility.